epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Journal Article Synopsis

JAMA Netw Open

5h

Surgery may beat GLP-1s on long-term costs

In adults with obesity and diabetes, bariatric metabolic surgery was linked to lower downstream health care costs than GLP-1 therapy. . .

Journal Article Synopsis

JAMA Netw Open

6h

Primary care CGM starts tied to lower A1c, fewer hospital visits

Among adults with insulin-treated diabetes, continuous glucose monitor use initiated without an endocrinology referral was tied to improvements on par with those seen in specialty settings. . .

Journal Article Synopsis

JAMA

7h

GLP-1 telehealth sites prescribe fast, skip screening

Secret shoppers got GLP-1 scripts from 45 of 49 online sellers, mostly within a day and some with no clinician contact at all. . .

Journal Article Synopsis

Ann Intern Med

7h

Can a virtual consult avert a patient transfer?

A systematic review links telemedicine-assisted transfer decisions with fewer interhospital transfers and no signal of increased mortality. . .

Government Health Agency News

FDA

8h

FDA grants first interchangeable rituximab biosimilar

Truxima's new designation may support broader biosimilar adoption across infusion centers and health systems.. . .
Journal Article Synopsis

Cancer

8h

Cancer screening gaps persist for sexual and gender minorities

National survey data reveal substantially lower breast and cervical cancer screening rates, especially among transgender individuals. . .
Internally Generated Content

Drug pipeline

9h

Novel intranasal therapy shows signal in very severe social anxiety disorder

Post hoc analysis identified a potential benefit in patients with very severe disease after the phase 3 trial missed its primary endpoint.. . .
Journal Article Synopsis

N Engl J Med

9h

Could a lower-cost MS therapy match ocrelizumab?

Rituximab, an off-label anti-CD20 option, matched ocrelizumab on MRI disease control in a phase 3 trial. . .

Journal Article Synopsis

Ann Intern Med

10h

Small sleep declines drove weight gain in at-risk adults

Six weeks of sleeping about 80 minutes less per night raised body weight and sedentary time in adults at cardiometabolic risk. . .
Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information